Back to search

Sweden· SE-20230214000051

Peigit 2 mg/0,02 mg Depottablett

A medicinal product containing dienogest + ethinylestradiol + lactose., registered in Sweden by Exeltis Healthcare, S.L..

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedPeigit 2 mg/0,02 mg DepottablettATC—REGISTER NO.SE-20230214000051PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Dienogest + Ethinylestradiol + Lactose.
Manufacturer
Exeltis Healthcare, S.L.
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20230214000051

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dienogest + ethinylestradiol + lactose. in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dienogest + ethinylestradiol + lactose. products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Kelzy
  • Belgium · Kelsee, Oedien
  • Czechia · Ardiena, Diecyclen
  • Germany · Dienacne, Kelzy
  • Denmark · Kelzyn
  • Estonia · Kelzy, Sibilla Plus
  • Spain · Adieris Diario, Kelzy
  • Finland · Cemisiana, Dienorette
  • France · Dienille Continu, Dienille Continu 2 Mg/0.03 Mg
  • United Kingdom (Northern Ireland) · Serisima Ed
  • Hungary · Kelsee, Mistral Continuous
  • Ireland · Kelzy
  • Italy · Aglae, Dailyprev
  • Lithuania · Kelzy
  • Luxembourg · Kelsee, Oedien
  • Latvia · Kelzy
  • Netherlands · Kelzyn
  • Norway · Kelzyn
  • Poland · Atywia Daily, Kelzy Pr
  • Portugal · Amelye, Kelzy
  • Slovakia · Diecyclen, Kelzy

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/780ee77b-4a10-4f26-bc3f-edc01ccca24d
GET /v1/drugs/780ee77b-4a10-4f26-bc3f-edc01ccca24d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "sPAR",
    "PL",
    "PAR",
    "sRMP",
    "SmPC"
  ],
  "se_npl_id": "20230214000051",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20230214000051",
  "product_doc_link": "https://docetp.mpa.se/LMF/Peigit%20prolonged-release%20tablet%20ENG%20SmPC_09001bee83c7b7ff.pdf"
}

See everything about dienogest + ethinylestradiol + lactose..

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.